TrialThe Journal of antimicrobial chemotherapy2011

Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study.

Kathleen E Squires et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.